| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |